The Human Variable 

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating, multi-system neuroimmune disease on par with multiple sclerosis or congestive heart failure in severity, but for decades, it’s been sidelined by global health systems. Underdiagnosis, outdated clinical criteria, systemic bias, and institutional inertia have obscured its true scale. The result: tens of millions worldwide excluded from diagnosis, care, or recognition.

Les Affections Chroniques Associées à une Infection (IACCs), y compris le Covid Long, l'Encéphalomyélite Myalgique/Syndrome de Fatigue Chronique (EM/SFC), le Syndrome de Tachycardie Orthostatique Posturale (POTS), le Syndrome d'Activation des Mastocytes (SAMA), les Affections Pédiatriques PANS/PANDAS et les syndromes post-infectieux persistants tels que le Lyme chronique, émergent de perturbations systémiques qui se chevauchent

Infection-associated chronic conditions (IACCs) such as Long COVID, ME/CFS, POTS, and MCAS are not disparate diagnoses — they are systemic sequelae following immune injury. For too long, medicine has treated these illnesses as anomalies or mysteries, when in fact, they follow a biologically predictable pattern of dysregulation.